Harvard Catalyst Profiles

Harvard T. H. Chan School of Public Health, Boston, MA	ScD	05/2005	Social Determinants of Health
Harvard T. H. Chan School of Public Health, Boston, MA	MS	12/2004	Health & Social Behavior
Harvard T. H. Chan School of Public Health, Boston, MA	MS	05/1999	Epidemiology (Pharmco)
Yale School of Medicine, New Haven, CT	MPH	05/1992	Psychosocial/Chronic Disease Epidemiology

Dr. Linda Marc is a public health practitioner who is currently the Associate Dean of Public Health Practice & Continuing Education at Walden University, College of Health Sciences, was formerly the Associate Vice Chair of Research within the Department of Psychiatry at Boston University Medical Center.

At the Harvard T.H. Chan School of Public Health, in 2024, Dr Marc was appointed a Senior Research Fellow within the Division of Policy, Translation and Leadership Development, and since 2017 she has been an Instructor of Applied Practice and Integrative Learning in the Quantitative Methods Program, Department of Biostatistics. Immediately prior, Dr. Marc held an appointment as a Lecturer in Public Health Practice at the Yale School of Public Health (2006-2017), and served as the Principal Investigator of a DEI strategy implemented by the Dean's Office and Board of Directors. Outcomes improved school governance, diversification of the workforce, and equity across departments (https://medicine.yale.edu/profile/132195/).

As a practitioner, Dr. Marc is the CEO and Chief Science Officer of Behavioral Science International, LLC (https://behavioralscienceintl.com/), a public health consulting firm, which she founded in 1997 concurrent during her doctoral work at Harvard Chan. Dr. Marc's research interests have included diversity in clinical trials and measurement of patient reported outcomes (i.e., quality of life). A partial list of clients include Aventis,GSK, Pfizer, and Warner Lambert. She was formerly employed as a Scientist/Epidemiologist at Astra Merck, Novarits and Wyeth Ayerst Research. Her doctoral dissertation is entitled, "Social Determinants of Therapeutic Effectiveness During Initial Therapy of HIV-1 Infection, funded by GlaxoSmithKline, Pfizer and Novartis.

As a practitioner in the field, from 2017-2021, Dr. Marc was the National Implementation Director of a $21 million ($5.325 million/year) HRSA-funded HIV initiative. She was responsible for the design and delivery of technical assistance to adapt and implement 11 HIV behavioral interventions across 26 Ryan White HIV program-funded sites in the US (including Alaska and Puerto Rico).

From 2011-2017, Dr. Marc was the Education and Curriculum Development Director within the Harvard Center for Public Health, and served as the lead faculty ensuring that topics on social determinants were included in online instructional modules. In this capacity, she concurrently served as an Advisor on HIV and social determinants of health to the Haitian Ministry of Population and Public Health. Haiti projects focused on: (1) the utilization of mental health services for female victims of sexual violence; (2) uptake to post-exposure antiretroviral prophylaxis for victims of sexual violence; (3) measurement of sexual violence amongst internally displaced women living in post-earthquake camps; and (4) measurement of depression in the Haitian LGBT communities in collaboration with the Haiti PEPFAR Team on the first Bio-Behavioral Surveillance Study of MSM.

Due to her knowledge and research on the Haitian population, in 2006, Dr. Marc was appointed by the US Secretary of Commerce Carlos Guitierrez, to serve as an Advisor to the US Census Bureau, Race & Ethnicity Advisory Committee (REAC) through 2011.(https://www.census.gov/newsroom/releases/archives/miscellaneous/cb12-r42.html)

In 2012, the Census Bureau re-appointed Dr. Marc to serve as the Convenor of the Race & Hispanic Origin Research Working Group, for the newly formed National Advisory Committee on Race, Ethnicity and Other Populations (NAC). Throughout her 10 year tenure, both the REAC and NAC Committees were charged to explore alternative approaches for collecting race and ethnicity data from hard-to-reach and hard-to-count populations, for the 2010 and 2020 decennial census.

• HIV Infection
• Social Determinants of Health
• Quantitative Methods
• Implementation Science